- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
NHS Confederation appoints Niall Dickson as new Chief Executive
11 January 2017 • Author: Niamh Marriott, Digital Editor
The NHS Confederation today announced the appointment of Niall Dickson as its new Chief Executive.
Niall Dickson has long been a senior figure in health and social care. He has just completed seven years as Chief Executive of the General Medical Council and before that was Chief Executive of The King’s Fund. He was for many years the BBC’s Social Affairs Editor.
He takes over as Chief Executive of the NHS Confederation on 1st February 2017.
NHS Confederation Chairman Stephen Dorrell, said:
“This appointment is a major coup for the NHS Confederation and will add enormous value to the myriad of skills and experience we already possess at this organisation.
“Niall will help ensure the NHS Confederation remains the first port-of-call when the health service needs a voice, binding in the highest levels of experience and influence across the full spectrum of health and care services.
“He brings with him a diverse range of skills and experience including superb leadership, a strong record of innovation and delivery, and a raft of invaluable contacts and carefully nurtured relationships in key areas.
“The NHS Confederation has made enormous progress under the interim stewardship of Stephen Dalton who has expertly navigated us through a period of change and uncertainty. Stephen Dalton is a massively respected and admired colleague who receives the best of wishes from everyone at the Confederation.”
Niall Dickson said:
“The health and social care system is under massive strain facing unprecedented demand and severely constrained funding. It’s a great privilege to join the Confederation as it works with its members and partners to deliver better, safer care and the fundamental reforms that are needed to make the system sustainable. These are monumental challenges and there has never been a more important time for its various parts to come together locally and nationally.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Butterworth Laboratories Ltd CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe Kaiser Optical Systems Inc. L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics